Profile: TD2 Inc. specializes in providing drug development services. specializes in quantitative analyses of small molecule and potential anti-cancer agents and possible metabolites. We offer bioanalytical method development services and transfer under a non-GLP environment, with proper evaluation based on parameters according to FDA guidance. In vitro assays include microsomal stability, hepatocyte stability, S9 stability, plasma stability and recombinant enzyme stability assays to determine the extent of metabolic stability in vitro. We can perform microsomal binding studies to understand the free concentration available in the microsomal incubations.